Crossmark

Glucagon-like peptide-1 receptor agonist use is associated with lower blood ferritin levels in people with type 2 diabetes and hemochromatosis: a nationwide register-based study

Crossref DOI link: https://doi.org/10.1136/bmjdrc-2022-003300

Published Online: 2023-06-16

Published Print: 2023-06

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Bain, Stephen C

Carstensen, Bendix

Hyveled, Liselotte

Seremetis, Stephanie

Flindt Kreiner, Frederik https://orcid.org/0000-0001-8296-453X
Amadid, Hanan

Clark, Alice
Funding

Funding for this research was provided by:

Novo Nordisk A/S (Not applicable)
License Information

License valid from 2023-06-16

Document is current

Any future updates will be listed below